Bristol Myers Squibb
Bristol Myers Squibb is in pahse 1 of research to develop SARS-CoV-2 mAb Duo for COVID-19 therapy or prevention
Rankings by
National Ranking91st
in United States Regional Ranking99th
in North America and Caribbean Global Ranking251st
worldwide